Jurgen Krause is a notable inventor based in Ummendorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of amino acid derivatives. With a total of 3 patents to his name, Krause's work focuses on innovative solutions for treating obesity.

Latest Patents

Krause's latest patents include formulations of amino acid derivatives that are suitable for the treatment of obesity. One exemplary compound from his research is (R,S)-N²-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-N⁵-(1H-imidazol-2-yl)-ornithinamide. Another notable compound is (R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-argininamide-acetate. These inventions highlight his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Krause has worked with reputable companies such as Dr. Karl Thomae GmbH and Karl Thomae GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Krause has collaborated with esteemed colleagues, including Klaus Rudolf and Wolfgang Eberlein. These partnerships have contributed to the success of his projects and the advancement of his research.

Conclusion

Jurgen Krause's contributions to the field of pharmaceuticals, particularly in the area of amino acid derivatives for obesity treatment, showcase his innovative spirit and dedication to improving health outcomes. His work continues to influence the pharmaceutical industry and inspire future research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com